Image credit- flickr.com
GE Healthcare has partnered with the government of Sweden to open a $15.9 million centre in Uppsala that focuses on advancing manufacturing capabilities and the commercialization of new technologies in life sciences.
Testa Centre is a 2,500 square-meter facility that houses four bioprocessing laboratories with GE Healthcare technologies for testing new discoveries intended to enable the production of biopharmaceuticals, including bioreactors with working volumes up to 500 L for mammalian cell cultures, 50 L for bacterial and chromatography equipment from lab to pilot scale.
Open to academia, startups, and industry, Testa Centre is designed to help organizations achieve a more time and cost-effective way to reduce the risks of securing industrial Proof-of-Concept, in order to support the development of digital, technical, and biological innovations.
